| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |